Burkly Linda 4
4 · Editas Medicine, Inc. · Filed Mar 27, 2025
Insider Transaction Report
Form 4
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Option (right to buy)
2025-03-08+70,000→ 70,000 totalExercise: $1.72Exp: 2035-03-07→ Common Stock (70,000 underlying) - Award
Stock Option (right to buy)
2025-03-08+275,100→ 275,100 totalExercise: $1.72Exp: 2035-03-07→ Common Stock (275,100 underlying)
Footnotes (2)
- [F1]This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029.
- [F2]This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026.